Mikio Aoki
Mikio Aoki publishes mostly in Molecular Biology, Physiology and Immunology, on topics such as Alzheimer's disease research and treatments, Neonatal Respiratory Health Research and Immune Cell Function and Interaction.
- World rank
- #3,373,071 of 7,710,434 ranked researchers
- Rank in Japan
- #80,815 of 383,136
- Works
- 85
- Citations
- 1.3k
- Citations per work
- 15.3
What does Mikio Aoki research?
Mikio Aoki's work is mostly in Medicine (24%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4250.0%
- Life Sciences2225.5%
- Health Sciences2124.5%
- Medicine2124.5%
- 1Molecular Biology17% of their works
- 2Physiology10% of their works
- 3Immunology8% of their works
- 4Pulmonary and Respiratory Medicine7% of their works
- 5Oncology4% of their works
- 6Pharmacology3% of their works
Research topics
- Alzheimer's disease research and treatments
- Neonatal Respiratory Health Research
- Immune Cell Function and Interaction
- Computational Drug Discovery Methods
- Cholinesterase and Neurodegenerative Diseases
- Cellular transport and secretion
- RNA Interference and Gene Delivery
- Metabolomics and Mass Spectrometry Studies
Which keywords describe Mikio Aoki's research?
The keywords of their largest research topics: Amyloid Hypothesis, Tau Pathology, Bronchopulmonary Dysplasia, Preterm Infants, Acetylcholinesterase, Cholinesterase Inhibitors, Molecular Docking and Natural Killer Cells.
- siRNA Delivery
- Metabolomics
- Mass Spectrometry
- Virtual Screening
- NK Cell Recognition
- Cholinesterase Inhibitors
- Preterm Infants
- Tau Pathology
- Amyloid Hypothesis
- Bronchopulmonary Dysplasia
- Acetylcholinesterase
- Molecular Docking
- Natural Killer Cells
- Endocytosis
- Membrane Fusion
- RNA Interference
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Amyloid Hypothesis161 topic
- Tau Pathology161 topic
- Bronchopulmonary Dysplasia51 topic
- Preterm Infants51 topic
- Acetylcholinesterase41 topic
- Cholinesterase Inhibitors41 topic
- Molecular Docking41 topic
- NK Cell Recognition41 topic
- Natural Killer Cells41 topic
- Virtual Screening41 topic
- Endocytosis31 topic
- Mass Spectrometry31 topic
- Membrane Fusion31 topic
- Metabolomics31 topic
- RNA Interference31 topic
- siRNA Delivery31 topic
Where does Mikio Aoki work?
Mikio Aoki's main affiliation in the publication record is Sumitomo Dainippon Pharma (Japan), Japan.
How many publications and citations does Mikio Aoki have?
OpenAlex counts 85 works and 1,304 citations for Mikio Aoki, an h-index of 22, ranking #3,373,071 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mikio Aoki. Posts are plain text and can be reported.